iLoF
Financiado
iLoF: AI-augmented photonics to identify and quantify disease biomarkers
iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery & development. Through advanced AI & photonics, we collect massive amounts of data to build a digital l...
iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery & development. Through advanced AI & photonics, we collect massive amounts of data to build a digital library of biomarkers & biological profiles, bringing together world-class physicists, biologists, & data scientists to get life-saving personalized treatments to patients faster. Our platform captures label-free patterns in biological liquid samples, to generate specific patient or disease signatures. The iLoF device generates multiple highly focused, non-destructive laser beams that interrogate the biological sample to obtain a digital signal of its light pattern. That signal is used to detect modifications providing a flexible & agnostic tool that is not limited to a single use or disease. The current project focuses on developing an Alzheimer’s disease (AD) clinical trial patient screening tool.
ver más
Duración del proyecto: 24 meses
Fecha Inicio: 2023-07-17
Fecha Fin: 2025-07-31
Fecha Fin: 2025-07-31
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-07-17
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIC-2023-ACCELERATOROPEN-01:
EIC Accelerator Open 2023
Cerrada
hace 1 año
Presupuesto
El presupuesto total del proyecto asciende a
4M€
Líder del proyecto
ILOF INTELLIGENT LAB ON FIBER UNIPESSOAL LDA
No se ha especificado una descripción o un objeto social para esta compañía.
